• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    172.19 Down 6.67(3.73%) 4:00PM EDT
    |After Hours : 172.21 Up 0.02 (0.01%) 4:52PM EDT
    Add to Portfolio
    Prev Close:178.86
    Open:178.02
    Bid:160.00 x 100
    Ask:174.48 x 500
    1y Target Est:225.61
    Beta:1.20622
    Earnings Date:Oct 21 - Oct 26 (Est.)
    Day's Range:171.68 - 180.26
    52wk Range:150.06 - 208.88
    Volume:1,636,439
    Avg Vol (3m):1,833,100
    Market Cap:38.94B
    P/E (ttm):58.81
    EPS (ttm):2.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 3.73%38.94B
    AMGNDown 2.64%115.09B
    BAXDown 0.77%20.98B

    Key Statistics

    Forward P/E (1 yr):28.84
    P/S (ttm):16.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.84
    Quarterly EPS Est (Sep-15) :1.01
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback